Industry Voices—The growing role of pharmacists in driving down drug costs through transparency

The first and second articles in this series focused on the promise and challenges with real-time prescription benefit (RTPB), including the need to move beyond transparency solely when ordering new prescriptions through the electronic health record.

This third article expands the focus of drug cost transparency to include all of a patient’s current medications and all relevant points of patient care and communications. While cost transparency to prescribers in EHRs is essential, there are many other relevant and important stakeholders in the care...